CHOP-like-14 compared to CHOP-like-21 for patients with aggressive lymphoma – a meta-analysis of randomized controlled trials.

MLA

Vidal, Liat, et al. “CHOP-like-14 Compared to CHOP-like-21 for Patients with Aggressive Lymphoma – a Meta-Analysis of Randomized Controlled Trials.” Acta Oncologica, vol. 55, no. 1, Jan. 2016, pp. 77–84. EBSCOhost, https://doi.org/10.3109/0284186X.2015.1043025.

APA

Vidal, L., Gurion, R., Raanani, P., Gafter-Gvili, A., Shpilberg, O., Monsef, I., & Ram, R. (2016). CHOP-like-14 compared to CHOP-like-21 for patients with aggressive lymphoma – a meta-analysis of randomized controlled trials. Acta Oncologica, 55(1), 77–84. https://doi.org/10.3109/0284186X.2015.1043025

Chicago

Vidal, Liat, Ronit Gurion, Pia Raanani, Anat Gafter-Gvili, Ofer Shpilberg, Ina Monsef, and Ron Ram. 2016. “CHOP-like-14 Compared to CHOP-like-21 for Patients with Aggressive Lymphoma – a Meta-Analysis of Randomized Controlled Trials.” Acta Oncologica 55 (1): 77–84. doi:10.3109/0284186X.2015.1043025.